Search Orphan Drug Designations and Approvals
-
Generic Name: | Somatropin | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Nutropin | ||||||||||||||||
Date Designated: | 03/06/1987 | ||||||||||||||||
Orphan Designation: | For use in the long-term treatment of children who have growth failure due to a lack of adequate endogenous growth hormone secretion. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Genentech, Inc. 460 Point San Bruno Boulevard South San Francisco, California 94080 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Somatropin |
---|---|---|
Trade Name: | Nutropin | |
Marketing Approval Date: | 10/17/1985 | |
Approved Labeled Indication: | ||
Exclusivity End Date: | 10/17/1992 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-